生技市场－全球产业规模、份额、趋势、机会和预测，按应用、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球生技市场规模为1.45兆美元，预计2030年将以12.85%的复合年增长率成长至2.99兆美元。生物技术涵盖生物系统和製程在开发产品和技术方面的应用，旨在促进人类健康、农业和工业发展。推动市场扩张的关键因素包括慢性病和传染病在全球日益普遍，这促使人们需要先进的治疗和诊断解决方案；以及基因组学、分子生物学和基因工程领域的持续进步。此外，对个人化医疗日益增长的需求也为市场发展提供了强劲动力。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球生物技术市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依应用领域（生物製药、生物资讯科技、生物工业、生物农业）
  • 按最终用户划分（生物技术和製药公司、研究机构和实验室、学术机构、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美生技市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲生物技术市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太生物技术市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲生物技术市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲生物技术市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球生技市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Novo Nordisk A/S
• Regeneron Pharmaceuticals Inc.
• Amgen, Inc.
• CSL Limited
• Gilead Sciences, Inc.
• Celgene Corporation
• Biogen Inc.
• Vertex Pharmaceuticals, Inc.
• Seagen Inc.
• Genmab A/S

第十六章：策略建议

第17章调查会社について・免责事项

The Global Biotechnology Market, valued at USD 1.45 Trillion in 2024, is projected to experience a CAGR of 12.85% to reach USD 2.99 Trillion by 2030. Biotechnology encompasses the application of biological systems and processes to develop products and technologies that advance human health, agriculture, and industrial processes. Key drivers supporting the market's expansion include the increasing global prevalence of chronic and infectious diseases, necessitating advanced therapeutic and diagnostic solutions, alongside continuous advancements in genomics, molecular biology, and genetic engineering. The growing demand for personalized medicine also provides substantial impetus for market development.

Key Market Drivers

The biotechnology market is significantly propelled by breakthroughs in genetic engineering and gene editing technologies. These advancements, exemplified by tools such as CRISPR, enable precise modifications to genetic material, offering unprecedented potential for treating diseases at their root cause. This has led to a rapid expansion in therapeutic development, moving beyond conventional small molecules and biologics. This momentum is clearly reflected in regulatory milestones, as according to RegMedNet, May 2025, FDA-Approved Cell and Gene Therapies, the US Food and Drug Administration approved nine cell and gene therapy products in 2024, signaling a robust pipeline translating into tangible patient solutions.

Key Market Challenges

The substantial capital investment necessitated by extensive research and development activities presents a considerable impediment to the growth of the global biotechnology market. Developing innovative biological systems and processes demands significant, long-term financial commitments, often over many years before a product can reach commercialization. This inherent financial burden acts as a barrier, particularly for smaller biotechnology firms, limiting their capacity to pursue novel therapeutic and diagnostic solutions. For larger entities, the high costs can lead to a more conservative investment strategy, focusing resources on fewer, higher-probability projects, which can slow the overall pace of innovation and restrict the diversity of product pipelines across the industry.

Key Market Trends

The adoption of artificial intelligence in drug discovery and development is revolutionizing the pharmaceutical pipeline by enhancing the speed and efficiency of identifying drug candidates, optimizing lead compounds, and predicting clinical outcomes. This technology reduces the time and cost traditionally associated with bringing new therapies to market. For instance, according to the Massachusetts Biotechnology Council, Massachusetts-headquartered biopharma companies collectively received $7.89 billion in venture capital funding in 2024, reflecting substantial investment in innovation that includes AI-driven methodologies. Further illustrating this trend, Bexorg, Inc. announced the completion of a $23 million Series A financing in October 2025, specifically aimed at advancing its integrated AI and whole-human brain platform for central nervous system drug discovery and development.

Key Market Players

• Novo Nordisk A/S
• Regeneron Pharmaceuticals Inc.
• Amgen, Inc.
• CSL Limited
• Gilead Sciences, Inc.
• Celgene Corporation
• Biogen Inc.
• Vertex Pharmaceuticals, Inc.
• Seagen Inc.
• Genmab A/S

Report Scope:

In this report, the Global Biotechnology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biotechnology Market, By Application:

• Biopharmaceuticals
• Bio-IT
• Bio- Industrial
• Bio-Agriculture

Biotechnology Market, By End User:

• Biotechnology & Pharmaceutical Companies
• Research Institutes & Laboratories
• Academic Institutions
• Others

Biotechnology Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Biotechnology Market.

Available Customizations:

Global Biotechnology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biotechnology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Biopharmaceuticals, Bio-IT, Bio- Industrial, Bio-Agriculture)
  • 5.2.2. By End User (Biotechnology & Pharmaceutical Companies, Research Institutes & Laboratories, Academic Institutions, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Biotechnology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Biotechnology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Biotechnology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Biotechnology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By End User

7. Europe Biotechnology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Biotechnology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By End User
  • 7.3.2. France Biotechnology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By End User
  • 7.3.3. United Kingdom Biotechnology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Biotechnology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Biotechnology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By End User

8. Asia Pacific Biotechnology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Biotechnology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By End User
  • 8.3.2. India Biotechnology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Biotechnology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Biotechnology Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Biotechnology Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application
      • 8.3.5.2.2. By End User

9. Middle East & Africa Biotechnology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Biotechnology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By End User
  • 9.3.2. UAE Biotechnology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By End User
  • 9.3.3. South Africa Biotechnology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By End User

10. South America Biotechnology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Biotechnology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By End User
  • 10.3.2. Colombia Biotechnology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By End User
  • 10.3.3. Argentina Biotechnology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Biotechnology Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Novo Nordisk A/S
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Regeneron Pharmaceuticals Inc.
• 15.3. Amgen, Inc.
• 15.4. CSL Limited
• 15.5. Gilead Sciences, Inc.
• 15.6. Celgene Corporation
• 15.7. Biogen Inc.
• 15.8. Vertex Pharmaceuticals, Inc.
• 15.9. Seagen Inc.
• 15.10. Genmab A/S

16. Strategic Recommendations

17. About Us & Disclaimer